Cargando…
Immunological Characterization of Plant-Based HIV-1 Gag/Dgp41 Virus-Like Particles
It is widely anticipated that a prophylactic vaccine may be needed to control the HIV/AIDS epidemic worldwide. Despite over two decades of research, a vaccine against HIV-1 remains elusive, although a recent clinical trial has shown promising results. Recent studies have focused on highly conserved...
Autores principales: | Kessans, Sarah A., Linhart, Mark D., Meador, Lydia R., Kilbourne, Jacquelyn, Hogue, Brenda G., Fromme, Petra, Matoba, Nobuyuki, Mor, Tsafrir S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795674/ https://www.ncbi.nlm.nih.gov/pubmed/26986483 http://dx.doi.org/10.1371/journal.pone.0151842 |
Ejemplares similares
-
Biological and biochemical characterization of HIV-1 Gag/dgp41 virus-like particles expressed in Nicotiana benthamiana
por: Kessans, Sarah A, et al.
Publicado: (2013) -
A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles
por: Meador, Lydia R., et al.
Publicado: (2017) -
P02-10. Plant expression of chimeric Gag/gp41 virus-like particles as a mucosally-targeted subunit vaccine against HIV-1
por: Kessans, SA, et al.
Publicado: (2009) -
Mucosal Vaccines from Plant Biotechnology
por: Mason, Hugh S., et al.
Publicado: (2015) -
Codelivery of improved immune complex and virus-like particle vaccines containing Zika virus envelope domain III synergistically enhances immunogenicity
por: Diamos, Andrew G., et al.
Publicado: (2020)